| 摘要 |
<p>The present invention relates to the use of an angiotensin II type 1 receptor antagonist alone, or in combination with a metabolically neutral antihypertensive substance, for the prevention and/or treatment of the metabolic syndrome. Examples of angiotensin II type 1 receptor antagonist are compounds of formula (I) and examples of metabolically neutral antihypertensive substance are calcium antagonist.</p> |
